Financialsexperimental

MARIMED INC. (MRMD). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.

USD in thousands

Cash Flow
Q2 FY26
30 Jun 2026
Q1 FY26
31 Mar 2026
Q4 FY25
31 Dec 2025
Q3 FY25
30 Sept 2025
Q2 FY25
30 Jun 2025
Q1 FY25
31 Mar 2025
Q4 FY24
31 Dec 2024
Q3 FY24
30 Sept 2024
Q2 FY24
30 Jun 2024
Q1 FY24
31 Mar 2024
Q4 FY23
31 Dec 2023
Q3 FY23
30 Sept 2023
Q2 FY23
30 Jun 2023
Q1 FY23
31 Mar 2023
Q4 FY22
31 Dec 2022
Q3 FY22
30 Sept 2022
Q2 FY22
30 Jun 2022
Q1 FY22
31 Mar 2022
Q4 FY21
31 Dec 2021
Q3 FY21
30 Sept 2021
Net loss attributable to common stockholders-3,589*-3,785-4,631*-3,132*-1,269*-5,452-8,204*-1,011*-1,651*-1,298-10,169*-4,259*-958*-6454,751*2,706*1,823*4,188-6,508.3*2,020
Net income attributable to noncontrolling interests18*18-10*7*-1*323*16*12*630*-10*23*-194*16*73*53110.1*103.1
Depreciation and amortization of property and equipment702598.4*
Depreciation and amortization of property and equipment2,331*2,1532,073*2,115*2,114*1,8072,161*1,803*2,008*1,9381,711*1,591*1,261*986917*
Amortization of intangible assets717*810809*674*969*949883*882*809*374844*844*780*557428*429*285*140172.1*
Amortization of stock grants22*
Stock-based compensation350*325382*382*549*547278*280*248*244219*296*297*2081,372*
Amortization of option grants2,4696,285.8*
Amortization of debt discount196*115120*117*117*10593*90*88*871,011*952*560*328
Amortization of warrants issued as payment for services received0*0*0*0*
Amortization of warrants attached to debt0*
Amortization of original debt issuance discount0*0*0*026*75*76*55
Amortization of debt issuance costs19*1819*18*18*1818*18*19*18
Amortization of stand-alone warrant issuances0*
Amortization of beneficial conversion feature0*
Payment-in-kind interest0*00*0*0*30-47*82*55*1465*2*181*118
Bad debt expense505*7660*-122*256*1,388-205*-116*-15*0245*-122*39*-443,698*40*0*147.5*35.6
Amortization of warrants attached to debt0*
Amortization of warrants issued with stock0*
Fees paid with stock0*274732.7*
Obligations settled with common stock0*00*1*1*13*5*1*12*2*460*159*
Present value adjustment of notes payable0-719*0*0*719
Loss on disposal of assets0*0-589*11*-145*-111-33*
Loss on obligations settled with equity0*
Gain on extinguishment of debt-0*-699
Loss on changes in fair value of investments0*0*0*00*-1*-23*-121-92*46*-10*-20-251*-727*48-169.2*-522.1
Other investment income-0*-954
Write-off of disposed assets35*10*0*906
Accounts receivable, net-629*-401-1,402*-328*1,604*-303-1,216*539*-1,237*707-1,095*-616*-1,317*-132-2,046*-1,302*-1,744*-1,810-811.2*
Gain on finance lease adjustment0*0*0*00*18*0*13
Deferred rents receivable0*00*0*0*-12-19*-18*-19*-18-19*-18*-19*-18-21*-12*-7*-92-70.1*
Writedown of prepaid purchase consideration0*0*
Inventory2,621*-2,6952,927*-1,215*-1,265*-4531,487*-3,836*-2,095*-3,738-1,101*581*-2,063*-3,246-1,168*-2,420*675*-2,4701,226.1*
Other current assets-499*9991,305*-321*-189*240479*-526*539*3912,460*3,537*-2,136*639-3,246*-706*-528*-739772.5*
Other investment income0*0*0*0
Other assets21*-19101*198*-363*-2,542-13*-485*1,856*63-56*-659*340*19-13*279*
Accounts payable-1,962*5233,531*23*-2,799*86-32*613*2,273*1,334507*730*3,099*-1,961-1,345*348*-1,188*3,212-1,993.5*
Accrued expenses and other-81*829259*1,296*-281*1,888-1,032*1,831*-136*1,091-1,708*403*-328*-207-289*-373*-37*217
Deferred revenue243*74-218*
Income taxes payable1,958*2,608-2,485*2,691*691*2,8294,879*655*116*1,838420*4,399*932*-2,806-174*1,663*-10,059*3,592
Net cash provided by operating activities2,219*9493,429*2,676*297*1,293-413*803*3,185*3,2103,234*7,900*1,275*-4,4991,737*3,595*-6,511*8,4907,607.1*
Purchases of property and equipment-298*-373-33*-559*-309*-266-1,058*-2,566*-4,968*-3,368-5,381*-5,963*-5,734*-3,052-2,155*-2,131*-3,839*-4,015-3,224.2*
Sales and excise taxes payable-443
Operating lease payments, net-6-5.7*
Business combinations, net of cash acquired, and asset purchases0*00*0*0*-2310*0*4,250*00*0*-8*2,995
Finance lease interest payments70*
Advances toward future business combinations and asset purchases0*00*0*0*50100*-485*0*485875*0*-50*300
Purchases of investments00*8674*
Other current liabilities-21.9*
Business acquisitions, net of cash acquired-0*-12,441,000*-305,000-53,500*
Purchases and renewals of cannabis licenses-200*-380-164*-0*-245*-56-49*-40*-358*-265-0*-25*-0*-601-271*
Proceeds from notes receivable0*00*0*0*2637*0*0*130*12*44*4343*57*
Acquisition of interest in subsidiary0*
Net cash used in investing activities-507*-753-197*-514*-554*-115-1,200*-2,124*-9,543*-4,266-6,348*-6,215*-6,497*-6,925-2,513*-2,874*-16,480*-4,377-3,218.2*
Return on investment0*0*
Proceeds from sale of investment0*0*
Proceeds from disposal of assets0*0*
Investment in Green Growth Group, Inc.-100
Due from third party0*0*0*030*69*53*7518*52*-14*20
Proceeds from mortgages0*0*2,000*00*0*0*1,1630*
Interest on notes receivable4369.5*
Issuance of notes receivable0*0*0*0*
Payment of third-party debt issuance costs in connection with debt0*0*0*1,541*
Proceeds from issuance of term loan29,100,000
Principal payments of mortgages-391*-414-390*-364*-340*-401-175*-69*-73*-65-66*-90*
Repayment and retirement of mortgages0*0*0*0*11,817*0*
Proceeds from Construction to Permanent Commercial Real Estate Mortgage Loan0*0*0*00*2,129*1,901*1,047
Proceeds from issuance of preferred stock0*0*
Principal payments of promissory notes-355*-236-190*-957*-1,441*-478-394*-530*-118*-135
Principal payments of finance leases-435*-444-342*-349*-304*-322-305*-576*-356*-320-202*-300*-131*-69-61*-64*-47*-55-8.6*
Equity issuance costs0*0*
Distributions-31*-49-22*-34*-23*-58-19*-37*-38*-45-30*-47*-47*-34-35*-40*-83*-101-109.1*
Proceeds from issuance of promissory notes0*0*
Net cash used in financing activities-1,212*-1,143-944*-1,704*-806*-1,259-893*917*1,316*1,6454,500*-3,061*-1,738*23,282-600*2,481*-2,565*-329-286.4*
Net decrease in cash and cash equivalents500*-9472,288*458*-1,063*-81-2,506*-404*-5,042*5891,386*-1,376*-6,960*11,858-1,376*3,202*-25,556*3,7844,102.5*
Proceeds from term loan0*0*0*00*0*0*
Cash and equivalents, beginning of year7,937*8,8846,596*6,138*7,201*7,2829,788*10,192*15,234*14,64513,259*14,635*21,595*9,73711,113*7,911*33,467*29,68325,580.5*
Cash and cash equivalents, end of period8,4377,9378,8846,5966,1387,2017,2829,78810,19215,23414,64513,25914,63521,5959,73711,1137,91133,46729,68325,580.5
Proceeds from exercise of warrants0*0*
Cash paid for interest1,882*1,7571,717*1,776*1,739*1,6781,788*1,859*1,357*1,685888*2,025*1,641*1,100624*473*345*302270.2*
Principal payments of term loan0*0*300*900*388*212422*437*174173.5*
Cash paid for income taxes92*46-785*70*2*00*0*750*127-485*603*1,005*5,2961,985*705*11,809*68201.7*
Redemption of minority interests0*0*
Notes payable issued to purchase property and equipment0*54*0*00*49*60*49
Renewal of existing operating leases0*94
Entry into new finance leases279*033*1,208*0*5665*1,427*876*513
Repayment and retirement of promissory notes0*0*0*00*0*0*5,50322.3*
Conversion of promissory notes0*400
Conversion of preferred stock to common stock0*0
Proceeds from exercise of stock options0*0*0*74*35*00*7*0*37.1*
Return of stock to the Company in connection with withholding taxes17*531*22*21*9
Operating lease right-of-use assets and liabilities0*
Present value of promissory notes issued as purchase consideration0*0*0*0*3,000*00*0*0*4,569
Exchange of preferred stock for preferred stock0*6,933
Finance lease right-of-use assets and liabilities5*514
Exchange of preferred stock for notes payable0*7,093
Write-off of finance leases0*
Common stock issued as purchase consideration0*0*0*0*991*0
Common stock issued as purchase consideration0*0*2,994
Common stock issued under licensing agreement121*
Entry into new operating leases0*5,366,000283,000*
Conversion of preferred stock to common stock0*0*0*4,2750*0*0*2,902*
Entry into new finance leases1,541,000*224,000
Adjustment to purchase price allocation to reclassify certain acquired intangible assets to goodwill0*569*0*0*
Conversion of debentures payable0*
Conversion of promissory notes to equity0*0*0*00*
Entry into new operating leases238*
Entry into new operating leases0*0*0
Return of stock-0*
Common stock issued to purchase minority interest in a subsidiary of the Company0*0*0*
Issuance of common stock associated with subscriptions10,730*
Warrants to issue common stock issued with debt0*0*0*00*0*0*5,454
Cashless exercise of warrants360*
Liability recorded for building improvements0*0*
Cashless exercise of stock options159*
Issuance of common stock associated with subscriptions0*0*0*00*0*2*390*
Return of common stock to the Company in connection with withholding taxes26*0*